<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id><journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id><journal-id journal-id-type="publisher-id">MGG3</journal-id><journal-title-group><journal-title>Molecular Genetics &#x00026; Genomic Medicine</journal-title></journal-title-group><issn pub-type="epub">2324-9269</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27247956</article-id><article-id pub-id-type="pmc">4867562</article-id><article-id pub-id-type="doi">10.1002/mgg3.203</article-id><article-id pub-id-type="publisher-id">MGG3203</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Variable expressivity and co&#x02010;occurrence of <styled-content style="italic-in-any-context">LDLR</styled-content> and <styled-content style="italic-in-any-context">LDLRAP1</styled-content> mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy</article-title><alt-title alt-title-type="left-running-head">A. C. Fahed <italic>et&#x000a0;al</italic>.</alt-title></title-group><contrib-group><contrib id="mgg3203-cr-0001" contrib-type="author"><name><surname>Fahed</surname><given-names>Akl C.</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="mgg3203-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="mgg3203-cr-0002" contrib-type="author"><name><surname>Khalaf</surname><given-names>Ruby</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3203-cr-0003" contrib-type="author"><name><surname>Salloum</surname><given-names>Rony</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3203-cr-0004" contrib-type="author"><name><surname>Andary</surname><given-names>Rabih R.</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3203-cr-0005" contrib-type="author"><name><surname>Safa</surname><given-names>Raya</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3203-cr-0006" contrib-type="author"><name><surname>El&#x02010;Rassy</surname><given-names>Inaam</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="mgg3203-cr-0007" contrib-type="author"><name><surname>Moubarak</surname><given-names>Elie</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="mgg3203-cr-0008" contrib-type="author"><name><surname>Azar</surname><given-names>Sami T.</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="mgg3203-cr-0009" contrib-type="author"><name><surname>Bitar</surname><given-names>Fadi F.</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="mgg3203-cr-0010" contrib-type="author" corresp="yes"><name><surname>Nemer</surname><given-names>Georges</given-names></name><xref ref-type="aff" rid="mgg3203-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="mgg3203-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Department of Biochemistry and Molecular Genetics</named-content><institution>American University of Beirut</institution><named-content content-type="city">Beirut</named-content><country country="LB">Lebanon</country></aff><aff id="mgg3203-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Department of Genetics</named-content><named-content content-type="organisation-division">Harvard Medical School and Department of Internal Medicine</named-content><institution>Massachusetts General Hospital</institution><named-content content-type="city">Boston</named-content><named-content content-type="country-part">Massachusetts</named-content></aff><aff id="mgg3203-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">National LDL Apheresis Center</named-content><institution>Dahr El&#x02010;Bashek Governmental University Hospital</institution><named-content content-type="city">Roumieh</named-content><country country="LB">Lebanon</country></aff><aff id="mgg3203-aff-0004"><label><sup>4</sup></label><named-content content-type="organisation-division">Department of Internal Medicine</named-content><institution>American University of Beirut</institution><named-content content-type="city">Beirut</named-content><country country="LB">Lebanon</country></aff><aff id="mgg3203-aff-0005"><label><sup>5</sup></label><named-content content-type="organisation-division">Department of Pediatrics and Adolescent Medicine</named-content><institution>American University of Beirut</institution><named-content content-type="city">Beirut</named-content><country country="LB">Lebanon</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Georges Nemer, Department of Biochemistry and Molecular Genetics, American University of Beirut, Bliss Street, Beirut, Lebanon. Tel: +9611350000 Ext 4876 Fax: +9611744464 E&#x02010;mail: <email>gn08@aub.edu.lb</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2016</year></pub-date><volume>4</volume><issue>3</issue><issue-id pub-id-type="doi">10.1002/mgg3.2016.4.issue-3</issue-id><fpage>283</fpage><lpage>291</lpage><history><date date-type="received"><day>04</day><month>11</month><year>2015</year></date><date date-type="rev-recd"><day>14</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>17</day><month>12</month><year>2015</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2016 The Authors. <italic>Molecular Genetics &#x00026; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:MGG3-4-283.pdf"/><abstract id="mgg3203-abs-0001"><title>Abstract</title><sec id="mgg3203-sec-0001"><title>Background</title><p>The familial inherited genetic disorder of lipoprotein metabolism affects more than 10 million individuals around the world. Lebanon is one of the several endemic areas for familial hypercholesterolemia (<styled-content style="fixed-case">FH</styled-content>) with a founder mutation in the low&#x02010;density lipoprotein cholesterol receptor (<italic><styled-content style="fixed-case">LDLR</styled-content></italic>) gene, responsible for most of the cases. We have previously shown that 16% of all familial cases with hypercholesterolemia do not show genotype segregation of <italic><styled-content style="fixed-case">LDLR</styled-content></italic> with the underlying phenotype.</p></sec><sec id="mgg3203-sec-0002"><title>Methods</title><p>We used Sanger sequencing to genotype 25 Lebanese families with severe <styled-content style="fixed-case">FH</styled-content> for the gene encoding the <styled-content style="fixed-case">LDLR</styled-content>&#x02010;associated protein (<italic><styled-content style="fixed-case">LDLRAP</styled-content>1</italic>), responsible for the recessive form of the disease starting with the four families that did not show any genotype&#x02010;phenotype correlation in our previous screening.</p></sec><sec id="mgg3203-sec-0003"><title>Results</title><p>We showed that the previously reported p.Q136* variant is linked to the hypercholesterolemia phenotype in the four families. In addition, we showed a variable phenotype between families and between members of the same family. One family exhibits mutations in both <italic><styled-content style="fixed-case">LDLR</styled-content></italic> and <italic><styled-content style="fixed-case">LDLRAP</styled-content>1</italic> with family members showing differential phenotypes unexplained by the underlying genotypes of the two genes.</p></sec><sec id="mgg3203-sec-0004"><title>Conclusion</title><p>The p.Q136* variant in <italic><styled-content style="fixed-case">LDLRAP</styled-content>1</italic> is yet another founder mutation in Lebanon and coupled with the <italic><styled-content style="fixed-case">LDLR</styled-content></italic> p.C681* variant explains all the genetic causes of <styled-content style="fixed-case">FH</styled-content> in Lebanon.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="mgg3203-kwd-0001">Familial Hypercholesterolemia</kwd><kwd id="mgg3203-kwd-0002"><italic>LDLRAP1</italic></kwd><kwd id="mgg3203-kwd-0003"><italic>LDLR</italic></kwd><kwd id="mgg3203-kwd-0004">founder mutation</kwd></kwd-group><funding-group><award-group><funding-source>National Council for Scientific Research of Lebanon (CNRS&#x02010;L)</funding-source></award-group></funding-group><counts><page-count count="9"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>mgg3203</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.8.9 mode:remove_FC converted:12.05.2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="mgg3203-sec-0005"><title>Introduction</title><p>Familial hypercholesterolemia (FH) (MIM#143890) is an inherited disorder caused by a defect that impairs the normal uptake in the liver of low&#x02010;density lipoprotein cholesterol (LDL&#x02010;C) from the blood (Khachadurian <xref rid="mgg3203-bib-0018" ref-type="ref">1964</xref>; Pullinger et&#x000a0;al. <xref rid="mgg3203-bib-0026" ref-type="ref">2003</xref>; Soutar and Naoumova <xref rid="mgg3203-bib-0035" ref-type="ref">2007</xref>; Kolovou et&#x000a0;al. <xref rid="mgg3203-bib-0020" ref-type="ref">2011</xref>). High LDL&#x02010;C in the blood deposits in tissues leads to a 20&#x02010;fold increase in the risk of coronary artery disease (Knowles et&#x000a0;al. <xref rid="mgg3203-bib-0019" ref-type="ref">2015</xref>). When the circulating LDL&#x02010;C levels are twice the normal values, the disease is called &#x0201c;heterozygous,&#x0201d; whereas the term &#x0201c;homozygous&#x0201d; is linked to levels that are at least fourfold higher than the normal levels (Singh and Bittner <xref rid="mgg3203-bib-0031" ref-type="ref">2015</xref>). We have suggested previously that the number of mutant alleles does not always correlate with the severity of the clinical phenotype (Fahed and Nemer <xref rid="mgg3203-bib-0008" ref-type="ref">2011</xref>). Based on the clinical phenotype, the prevalence of the disease has been estimated worldwide to be 1/500 for the &#x0201c;heterozygous form&#x0201d; and 1/1,000,000 for the &#x0201c;homozygous form&#x0201d; (Goldberg et&#x000a0;al. <xref rid="mgg3203-bib-0015" ref-type="ref">2011</xref>; Knowles et&#x000a0;al. <xref rid="mgg3203-bib-0019" ref-type="ref">2015</xref>; Lahtinen et&#x000a0;al. <xref rid="mgg3203-bib-0021" ref-type="ref">2015</xref>; Singh and Bittner <xref rid="mgg3203-bib-0031" ref-type="ref">2015</xref>). The number of affected individuals is estimated to be more than 10 millions worldwide, with a preponderant prevalence of the &#x0201c;heterozygous form&#x0201d; in some populations like the French Canadians, Afrikaners in South Africa, Indians in South Africa, Finns, and Lebanese reaching up to 1/67 in the Danish population (Benn et&#x000a0;al. <xref rid="mgg3203-bib-0004" ref-type="ref">2012</xref>; Singh and Bittner <xref rid="mgg3203-bib-0031" ref-type="ref">2015</xref>).</p><p>Mutations in three genes have been so far linked to the autosomal dominant form of the disease (ADH): the first encoding the LDL receptor (LDLR) (Brown and Goldstein <xref rid="mgg3203-bib-0005" ref-type="ref">1986</xref>), the second the apolipoprotein ApoB&#x02010;100 (Soria et&#x000a0;al. <xref rid="mgg3203-bib-0032" ref-type="ref">1989</xref>), and the third the pro&#x02010;protein convertase subtilin/kexin 9 (PCSK9) (Abifadel et&#x000a0;al. <xref rid="mgg3203-bib-0001" ref-type="ref">2003</xref>). Mutations in the <italic>LDLR</italic> gene account for nearly 70% of all ADH cases with more than 1600 mutations reported so far (<ext-link ext-link-type="uri" xlink:href="http://www.ucl.ac.uk/ldlr">http://www.ucl.ac.uk/ldlr</ext-link>), and with a clinical phenotype directly linked to gene dosage, albeit not uniform even among siblings (Fahed and Nemer <xref rid="mgg3203-bib-0008" ref-type="ref">2011</xref>; Singh and Bittner <xref rid="mgg3203-bib-0031" ref-type="ref">2015</xref>). Those in the <italic>APOB</italic> and <italic>PCSK9</italic> account for only 2&#x02013;5% of the cases in Europe, and &#x0003c;5% of all cases worldwide, respectively (Nissen et&#x000a0;al. <xref rid="mgg3203-bib-0024" ref-type="ref">1998</xref>; Rabes et&#x000a0;al. <xref rid="mgg3203-bib-0028" ref-type="ref">2000</xref>; Abifadel et&#x000a0;al. <xref rid="mgg3203-bib-0001" ref-type="ref">2003</xref>; Lahtinen et&#x000a0;al. <xref rid="mgg3203-bib-0021" ref-type="ref">2015</xref>; Singh and Bittner <xref rid="mgg3203-bib-0031" ref-type="ref">2015</xref>). The autosomal recessive form of the disease is caused by mutations in the gene encoding the LDLR&#x02010;associated protein 1 (LDLRAP1), which is an adaptor protein that binds directly to the LDLR protein and mediates its cellular internalization via the clathrin machinery (Wilund et&#x000a0;al. <xref rid="mgg3203-bib-0040" ref-type="ref">2002</xref>; Cohen et&#x000a0;al. <xref rid="mgg3203-bib-0007" ref-type="ref">2003</xref>; Tietge et&#x000a0;al. <xref rid="mgg3203-bib-0038" ref-type="ref">2003</xref>; Pisciotta et&#x000a0;al. <xref rid="mgg3203-bib-0025" ref-type="ref">2006</xref>; Robles&#x02010;Osorio et&#x000a0;al. <xref rid="mgg3203-bib-0029" ref-type="ref">2006</xref>; Quagliarini et&#x000a0;al. <xref rid="mgg3203-bib-0027" ref-type="ref">2007</xref>; Soutar and Naoumova <xref rid="mgg3203-bib-0035" ref-type="ref">2007</xref>; Soutar <xref rid="mgg3203-bib-0034" ref-type="ref">2010</xref>). Similar to the case of the <italic>LDLR</italic>, some mutations in <italic>LDLRAP1</italic> are geographically linked mainly in Europe with a pronounced founder effect (Garcia et&#x000a0;al. <xref rid="mgg3203-bib-0014" ref-type="ref">2001</xref>; Wilund et&#x000a0;al. <xref rid="mgg3203-bib-0040" ref-type="ref">2002</xref>; Cohen et&#x000a0;al. <xref rid="mgg3203-bib-0007" ref-type="ref">2003</xref>; Pisciotta et&#x000a0;al. <xref rid="mgg3203-bib-0025" ref-type="ref">2006</xref>; Quagliarini et&#x000a0;al. <xref rid="mgg3203-bib-0027" ref-type="ref">2007</xref>).</p><p>The Lebanese National FH Database has recruited so far 124 patients clinically diagnosed with FH through identification of severe index cases undergoing or referred to LDL apheresis, and subsequent cascade screening of family members (Fahed and Nemer <xref rid="mgg3203-bib-0008" ref-type="ref">2011</xref>; Fahed et&#x000a0;al. <xref rid="mgg3203-bib-0009" ref-type="ref">2011</xref>, <xref rid="mgg3203-bib-0010" ref-type="ref">2012</xref>). The patients belong to 25 families from different parts of the country. We previously reported major findings from this database based on sequencing of <italic>LDLR</italic>,<italic> PCSK9</italic>, and <italic>APOB</italic> on 80 patients, and we noted that 27.5% of patients belonging to four families did not have a genetic explanation for the phenotype. In order to close this gap, we hereby report the sequencing results of all the three genes in the remaining four families in addition to those of the <italic>LDLRAP1</italic> genes in all patients of the database. We explain the genetic cause of FH in 100% of patients. We subsequently focus on understanding the phenotype in 44 patients belonging to four families with mutations in <italic>LDLRAP1</italic> gene in light of the concomitant presence of mutations for both <italic>LDLR</italic> and <italic>LDLRAP1</italic> within members of the same family.</p></sec><sec id="mgg3203-sec-0006"><title>Methodology</title><sec id="mgg3203-sec-0007"><title>Families and subjects</title><p>The study was approved by the Institutional Review Board of the American University of Beirut. A national database of Lebanese FH patients was established at the American University of Beirut starting in 2008. Patients were recruited from the National LDL Apheresis Center, which is the only center for treatment of severe FH in Lebanon. This was subsequently followed by cascade recruitment and screening of family members. Community visits aided in recruitment of multiplex families. Blood was collected from all subjects for DNA extraction and for fasting lipid level testing. For patients on LDL apheresis, fasting lipid profile testing was collected before apheresis sessions. Clinical data were also extracted from existing medical records.</p></sec><sec id="mgg3203-sec-0008"><title>Genetic studies</title><p>DNA extraction from blood was performed using a Qiagen kit (27220 Turnberry Lane Suite 200. Valencia, CA 91355, USA), following the manufacturer's protocol. Primers flanking all exons of the <italic>LDLR</italic>,<italic> LDLRAP1</italic>, and <italic>PCSK9</italic>, and exon 26 of <italic>APOB</italic> were sequenced in all subjects. Amplicons flanked exons by at least 50&#x000a0;bp from each side to identify splicing mutations. Sequencing was performed using the ABI3100A sequencer at the Molecular Core Facility at the American University of Beirut, following manufacturer's protocol, and as described previously (Nemer et&#x000a0;al. <xref rid="mgg3203-bib-0023" ref-type="ref">2006</xref>; Yehya et&#x000a0;al. <xref rid="mgg3203-bib-0041" ref-type="ref">2006</xref>).</p></sec></sec><sec id="mgg3203-sec-0009"><title>Results</title><sec id="mgg3203-sec-0010"><title>Families and subjects</title><p>A total of 25 families (a total of 124 individuals) with FH were recruited as part of the Lebanese National FH Database between 2008 and 2012. Twenty&#x02010;one families carried mutations in <italic>LDLR</italic> gene and whose phenotype was explained by these mutations. Sanger sequencing of the remaining four families (A, B, C, and D) showed a previously reported mutation in <italic>LDLRAP1</italic> (Figs.&#x000a0;<xref rid="mgg3203-fig-0001" ref-type="fig">1</xref>, <xref rid="mgg3203-fig-0002" ref-type="fig">2</xref>, <xref rid="mgg3203-fig-0003" ref-type="fig">3</xref>) and are the focus of this study. Out of 44 subjects recruited from these families, 18 had normal LDL&#x02010;C, 9 had mild FH, and 17 had severe FH (Table&#x000a0;<xref rid="mgg3203-tbl-0001" ref-type="table-wrap">1</xref>). The median age of subjects was 39.5&#x000a0;years (range 7&#x02013;70). Their average LDL&#x02010;C level was 270.5&#x000a0;mg/dL. Twelve (27%) subjects had xanthomas and 4 (11%) had xanthelasmas.</p><fig fig-type="Figure" xml:lang="en" id="mgg3203-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Sequencing results of the <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLRAP1</styled-content></styled-content> gene. Chromatograms showing part of exon 4 for the (A) wild&#x02010;type, (B) heterozygous, and (C) homozygous p.Q136* variant (boxed).</p></caption><graphic id="nlm-graphic-3" xlink:href="MGG3-4-283-g001"/></fig><fig fig-type="Figure" xml:lang="en" id="mgg3203-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Familial cases of <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLRAP1</styled-content></styled-content>. Pedigrees of two families A and B with only the p.Q136* variant and the associated phenotypes for each member.</p></caption><graphic id="nlm-graphic-5" xlink:href="MGG3-4-283-g002"/></fig><fig fig-type="Figure" xml:lang="en" id="mgg3203-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Co&#x02010;occurrence of <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLR</styled-content></styled-content> and <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLRAP1</styled-content></styled-content> mutations in familial cases. Pedigrees of two families C and D distantly related with the different genotypes in <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLR</styled-content></styled-content> (p.C681*, p.A391T) and <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLRAP1</styled-content></styled-content> (p.Q136*) and their corresponding phenotypes.</p></caption><graphic id="nlm-graphic-7" xlink:href="MGG3-4-283-g003"/></fig><table-wrap id="mgg3203-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Lipid levels and general characteristics of families enrolled in the study</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><tbody><tr><td align="left" colspan="2" rowspan="1">Subjects description</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Families</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Total subjects</td><td align="left" rowspan="1" colspan="1">44</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">With normal LDL</td><td align="left" rowspan="1" colspan="1">18</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">With mild FH</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">With severe FH</td><td align="left" rowspan="1" colspan="1">17</td></tr><tr><td align="left" colspan="2" rowspan="1">Characteristics</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Mean</td><td align="left" rowspan="1" colspan="1">38.4</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Median</td><td align="left" rowspan="1" colspan="1">39.5</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Range</td><td align="left" rowspan="1" colspan="1">7&#x02013;70</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">16 (36%)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">28 (64%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">External manifestations</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Xanthomas</td><td align="left" rowspan="1" colspan="1">12 (27%)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Xanthelasmas</td><td align="left" rowspan="1" colspan="1">5 (11%)</td></tr><tr><td align="left" colspan="2" rowspan="1">Lipid levels</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TC (mg/dL)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Average</td><td align="left" rowspan="1" colspan="1">360</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Range</td><td align="left" rowspan="1" colspan="1">185&#x02013;661</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1">150</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LDL (mg/dL)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Average</td><td align="left" rowspan="1" colspan="1">270.5</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Range</td><td align="left" rowspan="1" colspan="1">91&#x02013;582</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1">144.48</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">HDL (mg/dL)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Average</td><td align="left" rowspan="1" colspan="1">56.3</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Range</td><td align="left" rowspan="1" colspan="1">22&#x02013;126</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1">19.3</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">TG (mg/dL)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Average</td><td align="left" rowspan="1" colspan="1">162</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Range</td><td align="left" rowspan="1" colspan="1">66&#x02013;325</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">SD</td><td align="left" rowspan="1" colspan="1">67</td></tr></tbody></table><table-wrap-foot><fn id="mgg3203-note-0002"><p>LDL, low&#x02010;density lipoprotein; FH, familial hypercholesterolemia; TC, total cholesterol; HDL, high&#x02010;density lipoprotein; TG, triglycedride; SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Table&#x000a0;<xref rid="mgg3203-tbl-0001" ref-type="table-wrap">1</xref> shows the characteristics of these 44 subjects. The pedigrees are shown in Figures&#x000a0;<xref rid="mgg3203-fig-0002" ref-type="fig">2</xref> (families A and B) and <xref rid="mgg3203-fig-0003" ref-type="fig">3</xref> (families C and D, distantly related).</p></sec><sec id="mgg3203-sec-0011"><title>Mutations in FH genes in Lebanon</title><p>All four families share the same <italic>LDLRAP1</italic> variant, c.C406T that leads to a truncated protein at position 136 (p.Q136*). Eighteen subjects were heterozygous for this variant and only 10 of them had normal LDL&#x02010;C levels (Table&#x000a0;<xref rid="mgg3203-tbl-0002" ref-type="table-wrap">2</xref>). The average LDL&#x02010;C for all heterozygotes was 218&#x000a0;&#x000b1;&#x000a0;124&#x000a0;mg/dL. Ten patients were homozygous for <italic>LDLRAP1</italic> p.Q136* and all had elevated LDL&#x02010;C levels (432&#x000a0;&#x000b1;&#x000a0;101&#x000a0;mg/dL). In families C and D, mutations in <italic>LDLR</italic> and <italic>LDRAP1</italic> co&#x02010;occurred in the same patient in various combinations. Table&#x000a0;<xref rid="mgg3203-tbl-0003" ref-type="table-wrap">3</xref> summarizes the average LDL&#x02010;C levels and external manifestations of disease for the different mutation combinations in the two genes.</p><table-wrap id="mgg3203-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>List of all different genetic variants causing <styled-content style="fixed-case">FH</styled-content> in <styled-content style="fixed-case">L</styled-content>ebanon with their respective inheritance pattern</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" valign="bottom" colspan="1">Gene</th><th align="left" rowspan="2" valign="bottom" colspan="1">Variant</th><th align="left" rowspan="2" valign="bottom" colspan="1">Amino acid name</th><th align="left" rowspan="2" valign="bottom" colspan="1">ExAc AF (%)</th><th align="left" rowspan="2" valign="bottom" colspan="1">Number of families</th><th align="left" rowspan="2" valign="bottom" colspan="1">Number of carriers, total (normal LDL&#x02010;C)</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Heterozygous</th><th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Homozygous</th><th align="left" rowspan="2" valign="bottom" colspan="1">Other populations reported</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Number of carriers (with normal LDL&#x02010;C)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Average&#x000a0;&#x000b1;&#x000a0;SD LDL&#x02010;C (mg/dL)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Number of carriers (with normal LDL&#x02010;C)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Average&#x000a0;&#x000b1;&#x000a0;SD LDL&#x02010;C (mg/dL)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>LDLR</italic>
</td><td align="left" rowspan="1" colspan="1">c.C2043A</td><td align="left" rowspan="1" colspan="1">p.C681*</td><td align="left" rowspan="1" colspan="1">8.26E&#x02010;06</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">47 (4)</td><td align="left" rowspan="1" colspan="1">24 (3)</td><td align="left" rowspan="1" colspan="1">257&#x000a0;&#x000b1;&#x000a0;111</td><td align="left" rowspan="1" colspan="1">23 (1)</td><td align="left" rowspan="1" colspan="1">490&#x000a0;&#x000b1;&#x000a0;145</td><td align="left" rowspan="1" colspan="1">Israel, Brazil, UK, USA</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>LDLR</italic>
</td><td align="left" rowspan="1" colspan="1">C.G1171A</td><td align="left" rowspan="1" colspan="1">p.A391T</td><td align="left" rowspan="1" colspan="1">0.0467</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">9 (4)</td><td align="left" rowspan="1" colspan="1">9 (4)</td><td align="left" rowspan="1" colspan="1">197&#x000a0;&#x000b1;&#x000a0;61</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">South Africa, Russia, Canada, Morocco, Denmark</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>LDLR</italic>
</td><td align="left" rowspan="1" colspan="1">c.T1352C</td><td align="left" rowspan="1" colspan="1">p.I451T</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">4 (1)</td><td align="left" rowspan="1" colspan="1">2 (1)</td><td align="left" rowspan="1" colspan="1">161&#x000a0;&#x000b1;&#x000a0;28</td><td align="left" rowspan="1" colspan="1">2 (0)</td><td align="left" rowspan="1" colspan="1">596&#x000a0;&#x000b1;&#x000a0;74</td><td align="left" rowspan="1" colspan="1">Greece, Netherlands</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>LDLR</italic>
</td><td align="left" rowspan="1" colspan="1">C.C2177T</td><td align="left" rowspan="1" colspan="1">p.T726I</td><td align="left" rowspan="1" colspan="1">0.006261</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2 (0</td><td align="left" rowspan="1" colspan="1">2 (0)</td><td align="left" rowspan="1" colspan="1">194</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">USA, UK, Netherlands, Germany, France</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>LDLR</italic>
</td><td align="left" rowspan="1" colspan="1">980_981insA</td><td align="left" rowspan="1" colspan="1">His327fsX5</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3 (0)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">2 (0)</td><td align="left" rowspan="1" colspan="1">589&#x000a0;&#x000b1;&#x000a0;26</td><td align="left" rowspan="1" colspan="1">Denmark</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>LDLRAP1</italic>
</td><td align="left" rowspan="1" colspan="1">c.C406T</td><td align="left" rowspan="1" colspan="1">p.Q136*</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">28 (10)</td><td align="left" rowspan="1" colspan="1">18 (10)</td><td align="left" rowspan="1" colspan="1">218&#x000a0;&#x000b1;&#x000a0;124</td><td align="left" rowspan="1" colspan="1">10 (0)</td><td align="left" rowspan="1" colspan="1">432&#x000a0;&#x000b1;&#x000a0;101</td><td align="left" rowspan="1" colspan="1">Turkey</td></tr></tbody></table><table-wrap-foot><fn id="mgg3203-note-0003"><p>FH, familial hypercholesterolemia; LDL&#x02010;C, low&#x02010;density lipoprotein cholesterol; SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="mgg3203-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Gentoype/phenotype of all patients with <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLR</styled-content></styled-content> and/or <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLRAP1</styled-content></styled-content> variants</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Genotype</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic>N</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">%</th><th align="left" valign="bottom" rowspan="1" colspan="1">LDL (mg/dL) (average&#x000a0;&#x000b1;&#x000a0;SD)</th><th align="left" valign="bottom" rowspan="1" colspan="1">XO</th><th align="left" valign="bottom" rowspan="1" colspan="1">XA</th><th align="left" valign="bottom" rowspan="1" colspan="1">LDL apheresis</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">No mutation</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">13.6</td><td align="left" rowspan="1" colspan="1">150&#x000a0;&#x000b1;&#x000a0;22</td><td align="left" rowspan="1" colspan="1">1/6</td><td align="left" rowspan="1" colspan="1">0/6</td><td align="left" rowspan="1" colspan="1">0/6</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLRAP hetero Q136*</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">25.0</td><td align="left" rowspan="1" colspan="1">184&#x000a0;&#x000b1;&#x000a0;116</td><td align="left" rowspan="1" colspan="1">0/11</td><td align="left" rowspan="1" colspan="1">0/11</td><td align="left" rowspan="1" colspan="1">1/11</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLRAP homo Q136*</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">20.5</td><td align="left" rowspan="1" colspan="1">391&#x000a0;&#x000b1;&#x000a0;95</td><td align="left" rowspan="1" colspan="1">7/9</td><td align="left" rowspan="1" colspan="1">3/9</td><td align="left" rowspan="1" colspan="1">5/9</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLR hetero A391T</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">6.8</td><td align="left" rowspan="1" colspan="1">156</td><td align="left" rowspan="1" colspan="1">0/3</td><td align="left" rowspan="1" colspan="1">0/3</td><td align="left" rowspan="1" colspan="1">0/3</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLR hetero C681*</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">11.4</td><td align="left" rowspan="1" colspan="1">242&#x000a0;&#x000b1;&#x000a0;88</td><td align="left" rowspan="1" colspan="1">1/5</td><td align="left" rowspan="1" colspan="1">1/5</td><td align="left" rowspan="1" colspan="1">0/5</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLR homo C681*</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2.3</td><td align="left" rowspan="1" colspan="1">189</td><td align="left" rowspan="1" colspan="1">0/1</td><td align="left" rowspan="1" colspan="1">0/1</td><td align="left" rowspan="1" colspan="1">0/1</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLRAP hetero Q136*&#x000a0;+&#x000a0;LDLR hetero C681*</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">238&#x000a0;&#x000b1;&#x000a0;134</td><td align="left" rowspan="1" colspan="1">1/2</td><td align="left" rowspan="1" colspan="1">0/2</td><td align="left" rowspan="1" colspan="1">0/2</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLRAP hetero Q136*&#x000a0;+&#x000a0;LDLR homo C681*</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2.3</td><td align="left" rowspan="1" colspan="1">497</td><td align="left" rowspan="1" colspan="1">1/1</td><td align="left" rowspan="1" colspan="1">1/1</td><td align="left" rowspan="1" colspan="1">0/1</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLRAP hetero Q136*&#x000a0;+&#x000a0;LDLR hetero A391T</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">9.1</td><td align="left" rowspan="1" colspan="1">174&#x000a0;&#x000b1;&#x000a0;11</td><td align="left" rowspan="1" colspan="1">0/4</td><td align="left" rowspan="1" colspan="1">0/4</td><td align="left" rowspan="1" colspan="1">0/4</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLRAP homo Q136*&#x000a0;+&#x000a0;LDLR hetero A391T</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2.3</td><td align="left" rowspan="1" colspan="1">582</td><td align="left" rowspan="1" colspan="1">1/1</td><td align="left" rowspan="1" colspan="1">0/1</td><td align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td align="left" rowspan="1" colspan="1">LDLR hetero C681*&#x000a0;+&#x000a0;LDLR hetero A391T&#x000a0;+&#x000a0;LDLRAP hetero Q136*</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2.3</td><td align="left" rowspan="1" colspan="1">304</td><td align="left" rowspan="1" colspan="1">0/1</td><td align="left" rowspan="1" colspan="1">0/1</td><td align="left" rowspan="1" colspan="1">0/1</td></tr></tbody></table><table-wrap-foot><fn id="mgg3203-note-0004"><p>
<italic>LDLR</italic>, low&#x02010;density lipoprotein cholesterol receptor; <italic>LDLRAP1</italic>, LDLR&#x02010;associated protein; LDL, low&#x02010;density lipoprotein; XO, xanthomas; XA, xanthelasmas; SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec></sec><sec id="mgg3203-sec-0012"><title>Discussion</title><p>FH is one of the best described genetic disorders in Lebanon with a high incidence in a small (four millions) and highly consanguineous population. By studying the entire registered FH population in Lebanon, we reported the prevalence of the <italic>LDLR</italic> p.C681* allele variant among affected individuals. In this report we close the genetic gap by unraveling the prevalence of yet another founder mutation in <italic>LDLRAP1</italic> that combined with the <italic>LDLR</italic> variants (p.C681*, p.H327fsX5, p.A391T, and p.I451T) accounts to 100% of the population prevalence of FH in Lebanon.</p><sec id="mgg3203-sec-0013"><title>Consanguinity, inbreeding, and founder mutations in FH</title><p>The high prevalence of consanguineous marriages in the Middle&#x02010;East and North African region contributes to a high prevalence of genetic disease, neonate deaths and miscarriages. Both dominant forms due to inbreeding and recessive forms of disease are increased. In Lebanon, the rate of these marriages was estimated to be around 35% based on a cross&#x02010;sectional study (Barbour and Salameh <xref rid="mgg3203-bib-0003" ref-type="ref">2009</xref>). It has been long debated that FH in Lebanon has a founder component linked directly to the high prevalence of consanguineous marriages. The characterization of the Lebanese allele in the <italic>LDLR</italic> gene (p.C681*) in Lebanese expatriates was corroborated recently by our group in showing that it accounts for 80% of the studied families in Lebanon (Table&#x000a0;<xref rid="mgg3203-tbl-0003" ref-type="table-wrap">3</xref>). Four percent of the families carried other <italic>LDLR</italic> variants, and the remaining 16% carried the p.Q136* <italic>LDLRAP1</italic> alone or in conjunction with the p.C681*. The high prevalence of consanguinity and inbreeding results in a higher prevalence of homozygous/severe disease as well as in compound heterozygosity of various disease alleles as seen in families C and D.</p><p>Five mutations in <italic>LDLR</italic> and one mutation in <italic>LDLRAP1</italic> explain the FH phenotype in 100% of Lebanese patients in the National FH Database (Table&#x000a0;<xref rid="mgg3203-tbl-0002" ref-type="table-wrap">2</xref>). All mutations have been reported in other populations, although primarily in patients of Lebanese ancestry. The <italic>LDLR</italic> p.C681* is present in 20 families, either as the only mutation or cosegregating with other FH&#x02010;causing mutations, such as in families C and D (Fig.&#x000a0;<xref rid="mgg3203-fig-0002" ref-type="fig">2</xref>).</p><p>Founder mutations for FH have been described in many populations, and the most studied one with its relative small population is Sardinia in Italy whereby two <italic>LDLRAP1</italic> variants (p.W22X and Fs144&#x0003e;X170) account for all the cases, and the estimated frequency of the heterozygous carriers is ~1:143 (Filigheddu et&#x000a0;al. <xref rid="mgg3203-bib-0012" ref-type="ref">2009</xref>). The <italic>LDLRAP1</italic> p.Q136* variant was previously described in a Lebanese expatriate family living in Sardinia (Garcia et&#x000a0;al. <xref rid="mgg3203-bib-0014" ref-type="ref">2001</xref>), and in two Turkish families with severely delayed LDL catabolism (Schmidt et&#x000a0;al. <xref rid="mgg3203-bib-0030" ref-type="ref">1998</xref>; Tietge et&#x000a0;al. <xref rid="mgg3203-bib-0038" ref-type="ref">2003</xref>; Soufi et&#x000a0;al. <xref rid="mgg3203-bib-0033" ref-type="ref">2013</xref>). The results of our current study suggest that the variant likely has a founder effect in Lebanon and is the second &#x0201c;Lebanese allele&#x0201d; for FH. It is also possible that the variant migrated between modern day Turkey and Lebanon due to intermarriages during the 600&#x02010;year Turkish Empire rule of Lebanon (Ottoman Empire 1299&#x02013;1922 AC).</p></sec><sec id="mgg3203-sec-0014"><title>Variable expressivity of FH mutations</title><p>Although founder mutations are usually associated with a viable phenotype that could be described as mild allowing the transmission of the genotypes across generations, in most cases of FH whether dominant or recessive, the clinical features appear very early on in the patients as is the case of the Lebanese <italic>LDLR</italic> allele (Khachadurian <xref rid="mgg3203-bib-0018" ref-type="ref">1964</xref>; Fahed et&#x000a0;al. <xref rid="mgg3203-bib-0009" ref-type="ref">2011</xref>). Management of such cases could thus be ameliorated based on family history. The big challenge remains, however, the variable expressivity of the phenotype despite sharing the same genotype.</p><p>The gaps in establishing phenotype&#x02013;genotype correlations might be overcome by whole exome sequencing of all affected and nonaffected familial cases. Although no single variant modifier allele has been linked so far to amelioration or exacerbation of the clinical phenotype when concomitant with a FH genotype, some variants have been previously reported in carriers of the dominant hypercholesterolemia mutations with low levels of LDL&#x02010;C (Brusgaard et&#x000a0;al. <xref rid="mgg3203-bib-0006" ref-type="ref">2010</xref>; Huijgen et&#x000a0;al. <xref rid="mgg3203-bib-0016" ref-type="ref">2012</xref>). These variants affect mainly <italic>PCSK9</italic>,<italic> APOB</italic>, and <italic>ANGPTL3</italic> (data not shown); total loss of the latter causes familial hypolipidemia (Musunuru et&#x000a0;al. <xref rid="mgg3203-bib-0022" ref-type="ref">2010</xref>). In our cohort of patients we failed to detect any potential causative variant in the three genes except for the <italic>PCSK9</italic> variant (p.R46L) which was previously associated with low LDL&#x02010;C levels in normal and hypercholesterolemia patients (Humphries et&#x000a0;al. <xref rid="mgg3203-bib-0017" ref-type="ref">2009</xref>), and was found in only one patient (HC28 in Fig.&#x000a0;<xref rid="mgg3203-fig-0002" ref-type="fig">2</xref>A). This patient has a very severe phenotype and thus the p.R46L variant has no effect on a case where the adaptor protein is presumably not produced, confirming thus, the hypothesis that the action of PCSK9 is dependent on its interaction directly or indirectly via the <italic>LDLR</italic> to <italic>LDLRAP1</italic> (Soutar and Naoumova <xref rid="mgg3203-bib-0035" ref-type="ref">2007</xref>; Fahed and Nemer <xref rid="mgg3203-bib-0008" ref-type="ref">2011</xref>; Urban et&#x000a0;al. <xref rid="mgg3203-bib-0039" ref-type="ref">2013</xref>). This contrasts the results obtained for the p.L21dup <italic>PCSK9</italic> allele found in patients with the p.C681* variant and conferring low LDL&#x02010;C levels (Abifadel et&#x000a0;al. <xref rid="mgg3203-bib-0002" ref-type="ref">2009</xref>).</p></sec><sec id="mgg3203-sec-0015"><title>Failure of the dominant and recessive dichotomy in FH</title><p>The concomitant presence of the two forms of FH, recessive and dominant, within the same family represents a major challenge for treatment and follow&#x02010;up because of the complexity of the phenotype. Only two cases such as the ones we are hereby reporting are published. The first reported a double heterozygous case for both <italic>LDLR</italic> and <italic>LDLRAP1</italic> suggesting that the additional <italic>LDLRAP1</italic> variant confers more severity to the phenotype observed in the <italic>LDLR</italic> variant alone (Tada et&#x000a0;al. <xref rid="mgg3203-bib-0036" ref-type="ref">2011</xref>). The second involves a Turkish family with the same homozygous p.Q136* <italic>LDLRAP1</italic> variant as in this report, in combination with the p.Q254P <italic>LDLR</italic> variant (Soufi et&#x000a0;al. <xref rid="mgg3203-bib-0033" ref-type="ref">2013</xref>). The authors noted that the phenotype observed in the patients with combined heterozygous <italic>LDLR</italic> variant and <italic>LDLRAP1</italic> homozygous variant is more severe than the one observed in the homozygous <italic>LDLR</italic> variant alone. In our case, we could not identify a universal pattern but we noticed that the combination of homozygous variant of one gene with the heterozygous variant of the other gene results in a drastic increase of LDL&#x02010;C levels as is the case of patient HC50 in family C and patient HC8 in family D (Fig.&#x000a0;<xref rid="mgg3203-fig-0003" ref-type="fig">3</xref>). Nevertheless, the presence of three heterozygous variants does not equally increase the LDL&#x02010;C levels as in the case of HC41 (Fig.&#x000a0;<xref rid="mgg3203-fig-0003" ref-type="fig">3</xref>).</p><p>While the gene <italic>LDLRAP1</italic> is presumed to act in a recessive fashion, we report heterozygous carriers of p.Q136* with a severe FH phenotype equivalent to the homozygous carriers (Figs.&#x000a0;<xref rid="mgg3203-fig-0002" ref-type="fig">2</xref>, <xref rid="mgg3203-fig-0003" ref-type="fig">3</xref>). This goes in parallel with our previous findings on the heterogeneous phenotypes observed in patients with the <italic>LDLR</italic> p.C681* variant (Fahed et&#x000a0;al. <xref rid="mgg3203-bib-0010" ref-type="ref">2012</xref>). While gene dosage of <italic>LDLR</italic> and <italic>LDRAP1</italic> is playing a role in dictating the serum LDL&#x02010;C levels, it is not possible to obtain enough statistical power with current numbers to better understand these associations. Other players such as environmental, genetic modifiers, and treatment are also likely confounding the relationship with LDL&#x02010;C levels. Finally, the polygenic nature of the disease is to be taken into consideration whereby in some cohorts up to 60% of the cases are still with no genetic clues (Talmud et&#x000a0;al. <xref rid="mgg3203-bib-0037" ref-type="ref">2013</xref>; Futema et&#x000a0;al. <xref rid="mgg3203-bib-0013" ref-type="ref">2015</xref>) (Fig.&#x000a0;<xref rid="mgg3203-fig-0004" ref-type="fig">4</xref>).</p><fig fig-type="Figure" xml:lang="en" id="mgg3203-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Diagram&#x000a0;of all <styled-content style="fixed-case"><styled-content style="italic-in-any-context">LDLRAP1</styled-content></styled-content> mutations ever reported and their location on the protein.</p></caption><graphic id="nlm-graphic-9" xlink:href="MGG3-4-283-g004"/></fig><p>Overall, a better understanding of the different genetic variants in the physiological context is required to better define the role of each of the players in cholesterol synthesis and uptake process in a particular patient. Whole&#x02010;genome sequencing of large cohorts of FH are needed to establish statistical power for better understanding of LDL&#x02010;C level modifiers. Meanwhile, cascade genetic screening allows identification of cases early and serum LDL&#x02010;C level remain the best predictor of cardiovascular disease risk (Fahed et&#x000a0;al. <xref rid="mgg3203-bib-0011" ref-type="ref">2014</xref>).</p></sec></sec><sec id="mgg3203-sec-0017"><title>Conflict of Interest</title><p>None declared.</p></sec></body><back><ack id="mgg3203-sec-0016"><title>Acknowledgments</title><p>We thank the families for their contribution to this research. We also thank members of the Congenital Heart Disease Genetic Program (CHDGP) for critical reading of the manuscript. This work is supported by a grant from the National Council for Scientific Research of Lebanon (CNRS&#x02010;L).</p></ack><ref-list content-type="cited-references" id="mgg3203-bibl-0001"><title>References</title><ref id="mgg3203-bib-0001"><mixed-citation publication-type="journal" id="mgg3203-cit-0001">
<string-name>
<surname>Abifadel</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Varret</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Rabes</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Allard</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Ouguerram</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Devillers</surname>
</string-name>, et&#x000a0;al. <year>2003</year>
<article-title>Mutations in PCSK9 cause autosomal dominant hypercholesterolemia</article-title>. <source>Nat. Genet.</source>
<volume>34</volume>:<fpage>154</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="pmid">12730697</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0002"><mixed-citation publication-type="journal" id="mgg3203-cit-0002">
<string-name>
<surname>Abifadel</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Rabes</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jambart</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Halaby</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Gannage&#x02010;Yared</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sarkis</surname>
</string-name>, et&#x000a0;al. <year>2009</year>
<article-title>The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene</article-title>. <source>Hum. Mutat.</source>
<volume>30</volume>:<fpage>E682</fpage>&#x02013;<lpage>E691</lpage>.<pub-id pub-id-type="pmid">19319977</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0003"><mixed-citation publication-type="journal" id="mgg3203-cit-0003">
<string-name>
<surname>Barbour</surname>, <given-names>B.</given-names>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Salameh</surname>
</string-name>. <year>2009</year>
<article-title>Consanguinity in Lebanon: prevalence, distribution and determinants</article-title>. <source>J. Biosoc. Sci.</source>
<volume>41</volume>:<fpage>505</fpage>&#x02013;<lpage>517</lpage>.<pub-id pub-id-type="pmid">19175949</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0004"><mixed-citation publication-type="journal" id="mgg3203-cit-0004">
<string-name>
<surname>Benn</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>G. F.</given-names>
<surname>Watts</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tybjaerg&#x02010;Hansen</surname>
</string-name>, and <string-name>
<given-names>B. G.</given-names>
<surname>Nordestgaard</surname>
</string-name>. <year>2012</year>
<article-title>Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol&#x02010;lowering medication</article-title>. <source>J. Clin. Endocrinol. Metab.</source>
<volume>97</volume>:<fpage>3956</fpage>&#x02013;<lpage>3964</lpage>.<pub-id pub-id-type="pmid">22893714</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0005"><mixed-citation publication-type="journal" id="mgg3203-cit-0005">
<string-name>
<surname>Brown</surname>, <given-names>M. S.</given-names>
</string-name>, and <string-name>
<given-names>J. L.</given-names>
<surname>Goldstein</surname>
</string-name>. <year>1986</year>
<article-title>A receptor&#x02010;mediated pathway for cholesterol homeostasis</article-title>. <source>Science</source>
<volume>232</volume>:<fpage>34</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">3513311</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0006"><mixed-citation publication-type="journal" id="mgg3203-cit-0006">
<string-name>
<surname>Brusgaard</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Kjaersgaard</surname>
</string-name>, <string-name>
<given-names>A. B.</given-names>
<surname>Hansen</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Husby</surname>
</string-name>. <year>2010</year>
<article-title>New mutations in APOB100 involved in familial hypobetalipoproteinemia</article-title>. <source>J. Clin. Lipidol.</source>
<volume>4</volume>:<fpage>181</fpage>&#x02013;<lpage>184</lpage>.<pub-id pub-id-type="pmid">21122650</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0007"><mixed-citation publication-type="journal" id="mgg3203-cit-0007">
<string-name>
<surname>Cohen</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kimmel</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Polanski</surname>
</string-name>, and <string-name>
<given-names>H. H.</given-names>
<surname>Hobbs</surname>
</string-name>. <year>2003</year>
<article-title>Molecular mechanisms of autosomal recessive hypercholesterolemia</article-title>. <source>Curr. Opin. Lipidol.</source>
<volume>14</volume>:<fpage>121</fpage>&#x02013;<lpage>127</lpage>.<pub-id pub-id-type="pmid">12642779</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0008"><mixed-citation publication-type="journal" id="mgg3203-cit-0008">
<string-name>
<surname>Fahed</surname>, <given-names>A. C.</given-names>
</string-name>, and <string-name>
<given-names>G. M.</given-names>
<surname>Nemer</surname>
</string-name>. <year>2011</year>
<article-title>Familial hypercholesterolemia: the lipids or the genes?</article-title>
<source>Nutr. Metab. (Lond.)</source>
<volume>8</volume>:<fpage>23</fpage>.<pub-id pub-id-type="pmid">21513517</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0009"><mixed-citation publication-type="journal" id="mgg3203-cit-0009">
<string-name>
<surname>Fahed</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>R. M.</given-names>
<surname>Safa</surname>
</string-name>, <string-name>
<given-names>F. F.</given-names>
<surname>Haddad</surname>
</string-name>, <string-name>
<given-names>F. F.</given-names>
<surname>Bitar</surname>
</string-name>, <string-name>
<given-names>R. R.</given-names>
<surname>Andary</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Arabi</surname>
</string-name>, et&#x000a0;al. <year>2011</year>
<article-title>Homozygous familial hypercholesterolemia in Lebanon: a genotype/phenotype correlation</article-title>. <source>Mol. Genet. Metab.</source>
<volume>102</volume>:<fpage>181</fpage>&#x02013;<lpage>188</lpage>.<pub-id pub-id-type="pmid">21145767</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0010"><mixed-citation publication-type="journal" id="mgg3203-cit-0010">
<string-name>
<surname>Fahed</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>F. F.</given-names>
<surname>Bitar</surname>
</string-name>, <string-name>
<given-names>R. I.</given-names>
<surname>Khalaf</surname>
</string-name>, <string-name>
<given-names>E. M.</given-names>
<surname>Moubarak</surname>
</string-name>, <string-name>
<given-names>S. T.</given-names>
<surname>Azar</surname>
</string-name>, and <string-name>
<given-names>G. M.</given-names>
<surname>Nemer</surname>
</string-name>. <year>2012</year>
<article-title>The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia</article-title>. <source>Endocrine</source>
<volume>42</volume>:<fpage>445</fpage>&#x02013;<lpage>448</lpage>.<pub-id pub-id-type="pmid">22487947</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0011"><mixed-citation publication-type="journal" id="mgg3203-cit-0011">
<string-name>
<surname>Fahed</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>R. H.</given-names>
<surname>Habib</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Nemer</surname>
</string-name>, <string-name>
<given-names>S. T.</given-names>
<surname>Azar</surname>
</string-name>, <string-name>
<given-names>R. R.</given-names>
<surname>Andary</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Arabi</surname>
</string-name>, et&#x000a0;al. <year>2014</year>
<article-title>Low&#x02010;density lipoprotein levels and not mutation status predict intima&#x02010;media thickness in familial hypercholesterolemia</article-title>. <source>Ann. Vasc. Surg.</source>
<volume>28</volume>:<fpage>421</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">24120234</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0012"><mixed-citation publication-type="journal" id="mgg3203-cit-0012">
<string-name>
<surname>Filigheddu</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Quagliarini</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Campagna</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Secci</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Degortes</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Zaninello</surname>
</string-name>, et&#x000a0;al. <year>2009</year>
<article-title>Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterolemia in Sardinia</article-title>. <source>Atherosclerosis</source>
<volume>207</volume>:<fpage>162</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">19477448</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0013"><mixed-citation publication-type="journal" id="mgg3203-cit-0013">
<string-name>
<surname>Futema</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Shah</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Cooper</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Whittall</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Sharifi</surname>
</string-name>, et&#x000a0;al. <year>2015</year>
<article-title>Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries</article-title>. <source>Clin. Chem.</source>
<volume>61</volume>:<fpage>231</fpage>&#x02013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">25414277</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0014"><mixed-citation publication-type="journal" id="mgg3203-cit-0014">
<string-name>
<surname>Garcia</surname>, <given-names>C. K.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Wilund</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Arca</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Zuliani</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Fellin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Maioli</surname>
</string-name>, et&#x000a0;al. <year>2001</year>
<article-title>Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein</article-title>. <source>Science</source>
<volume>292</volume>:<fpage>1394</fpage>&#x02013;<lpage>1398</lpage>.<pub-id pub-id-type="pmid">11326085</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0015"><mixed-citation publication-type="journal" id="mgg3203-cit-0015">
<string-name>
<surname>Goldberg</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>P. N.</given-names>
<surname>Hopkins</surname>
</string-name>, <string-name>
<given-names>P. P.</given-names>
<surname>Toth</surname>
</string-name>, <string-name>
<given-names>C. M.</given-names>
<surname>Ballantyne</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Rader</surname>
</string-name>, <string-name>
<given-names>J. G.</given-names>
<surname>Robinson</surname>
</string-name>, et&#x000a0;al. <year>2011</year>
<article-title>Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel&#x000a0;on Familial Hypercholesterolemia</article-title>. <source>J. Clin. Lipidol.</source>
<volume>5</volume>:<fpage>133</fpage>&#x02013;<lpage>140</lpage>.<pub-id pub-id-type="pmid">21600517</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0016"><mixed-citation publication-type="journal" id="mgg3203-cit-0016">
<string-name>
<surname>Huijgen</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Sjouke</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Vis</surname>
</string-name>, <string-name>
<given-names>J. S.</given-names>
<surname>de Randamie</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Defesche</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Kastelein</surname>
</string-name>, et&#x000a0;al. <year>2012</year>
<article-title>Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL&#x02010;Cl Levels</article-title>. <source>Hum. Mutat.</source>
<volume>33</volume>:<fpage>448</fpage>&#x02013;<lpage>455</lpage>.<pub-id pub-id-type="pmid">22095935</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0017"><mixed-citation publication-type="journal" id="mgg3203-cit-0017">
<string-name>
<surname>Humphries</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<given-names>R. D.</given-names>
<surname>Neely</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Whittall</surname>
</string-name>, <string-name>
<given-names>J. S.</given-names>
<surname>Troutt</surname>
</string-name>, <string-name>
<given-names>R. J.</given-names>
<surname>Konrad</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Scartezini</surname>
</string-name>, et&#x000a0;al. <year>2009</year>
<article-title>Healthy individuals carrying the PCSK9 p. R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9</article-title>. <source>Clin. Chem.</source>
<volume>55</volume>:<fpage>2153</fpage>&#x02013;<lpage>2161</lpage>.<pub-id pub-id-type="pmid">19797716</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0018"><mixed-citation publication-type="journal" id="mgg3203-cit-0018">
<string-name>
<surname>Khachadurian</surname>, <given-names>A. K.</given-names>
</string-name>
<year>1964</year>
<article-title>The inheritance of essential familial hypercholesterolemia</article-title>. <source>Am. J. Med.</source>
<volume>37</volume>:<fpage>402</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="pmid">14209286</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0019"><mixed-citation publication-type="journal" id="mgg3203-cit-0019">
<string-name>
<surname>Knowles</surname>, <given-names>J. W.</given-names>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Stone</surname>
</string-name>, and <string-name>
<given-names>C. M.</given-names>
<surname>Ballantyne</surname>
</string-name>. <year>2015</year>
<article-title>Familial hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: myths, oversimplification, and misinterpretation versus facts</article-title>. <source>Am. J. Cardiol.</source>
<volume>116</volume>:<fpage>481</fpage>&#x02013;<lpage>484</lpage>.<pub-id pub-id-type="pmid">26043952</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0020"><mixed-citation publication-type="journal" id="mgg3203-cit-0020">
<string-name>
<surname>Kolovou</surname>, <given-names>G. D.</given-names>
</string-name>, <string-name>
<given-names>P. M.</given-names>
<surname>Kostakou</surname>
</string-name>, and <string-name>
<given-names>K. K.</given-names>
<surname>Anagnostopoulou</surname>
</string-name>. <year>2011</year>
<article-title>Familial hypercholesterolemia and triglyceride metabolism</article-title>. <source>Int. J. Cardiol.</source>
<volume>147</volume>:<fpage>349</fpage>&#x02013;<lpage>358</lpage>.<pub-id pub-id-type="pmid">20826022</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0021"><mixed-citation publication-type="journal" id="mgg3203-cit-0021">
<string-name>
<surname>Lahtinen</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Havulinna</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Jula</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Salomaa</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Kontula</surname>
</string-name>. <year>2015</year>
<article-title>Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population</article-title>. <source>Atherosclerosis</source>
<volume>238</volume>:<fpage>64</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">25437892</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0022"><mixed-citation publication-type="journal" id="mgg3203-cit-0022">
<string-name>
<surname>Musunuru</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Pirruccello</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Do</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Peloso</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Guiducci</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Sougnez</surname>
</string-name>, et&#x000a0;al. <year>2010</year>
<article-title>Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia</article-title>. <source>N. Engl. J. Med.</source>
<volume>363</volume>:<fpage>2220</fpage>&#x02013;<lpage>2227</lpage>.<pub-id pub-id-type="pmid">20942659</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0023"><mixed-citation publication-type="journal" id="mgg3203-cit-0023">
<string-name>
<surname>Nemer</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Fadlalah</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Usta</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Nemer</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Dbaibo</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Obeid</surname>
</string-name>, et&#x000a0;al. <year>2006</year>
<article-title>A novel mutation in the GATA4 gene in patients with tetralogy of Fallot</article-title>. <source>Hum. Mutat.</source>
<volume>27</volume>:<fpage>293</fpage>&#x02013;<lpage>294</lpage>.<pub-id pub-id-type="pmid">16470721</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0024"><mixed-citation publication-type="journal" id="mgg3203-cit-0024">
<string-name>
<surname>Nissen</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Lestavel</surname>
</string-name>, <string-name>
<given-names>T. S.</given-names>
<surname>Hansen</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Luc</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Bruckert</surname>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Clavey</surname>
</string-name>. <year>1998</year>
<article-title>Mutation screening of the LDLR gene and ApoB gene in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay</article-title>. <source>Clin. Genet.</source>
<volume>54</volume>:<fpage>79</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">9727746</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0025"><mixed-citation publication-type="journal" id="mgg3203-cit-0025">
<string-name>
<surname>Pisciotta</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Priore Oliva</surname>
</string-name>, <string-name>
<given-names>G. M.</given-names>
<surname>Pes</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Di Scala</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Bellocchio</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Fresa</surname>
</string-name>, et&#x000a0;al. <year>2006</year>
<article-title>Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison</article-title>. <source>Atherosclerosis</source>
<volume>188</volume>:<fpage>398</fpage>&#x02013;<lpage>405</lpage>.<pub-id pub-id-type="pmid">16343504</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0026"><mixed-citation publication-type="journal" id="mgg3203-cit-0026">
<string-name>
<surname>Pullinger</surname>, <given-names>C. R.</given-names>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Kane</surname>
</string-name>, and <string-name>
<given-names>M. J.</given-names>
<surname>Malloy</surname>
</string-name>. <year>2003</year>
<article-title>Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders</article-title>. <source>Expert Rev. Cardiovasc. Ther.</source>
<volume>1</volume>:<fpage>107</fpage>&#x02013;<lpage>119</lpage>.<pub-id pub-id-type="pmid">15030301</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0027"><mixed-citation publication-type="journal" id="mgg3203-cit-0027">
<string-name>
<surname>Quagliarini</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Vallve</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Campagna</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Alvaro</surname>
</string-name>, <string-name>
<given-names>F. J.</given-names>
<surname>Fuentes&#x02010;Jimenez</surname>
</string-name>, <string-name>
<given-names>M. I.</given-names>
<surname>Sirinian</surname>
</string-name>, et&#x000a0;al. <year>2007</year>
<article-title>Autosomal recessive hypercholesterolemia in Spanish kindred due to a large deletion in the ARH gene</article-title>. <source>Mol. Genet. Metab.</source>
<volume>92</volume>:<fpage>243</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">17686643</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0028"><mixed-citation publication-type="journal" id="mgg3203-cit-0028">
<string-name>
<surname>Rabes</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Varret</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Devillers</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Aegerter</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Villeger</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Krempf</surname>
</string-name>, et&#x000a0;al. <year>2000</year>
<article-title>R3531C mutation in the apolipoprotein B gene is not sufficient to cause hypercholesterolemia</article-title>. <source>Arterioscler. Thromb. Vasc. Biol.</source>
<volume>20</volume>:<fpage>E76</fpage>&#x02013;<lpage>E82</lpage>.<pub-id pub-id-type="pmid">11031227</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0029"><mixed-citation publication-type="journal" id="mgg3203-cit-0029">
<string-name>
<surname>Robles&#x02010;Osorio</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Huerta&#x02010;Zepeda</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Ordonez</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Canizales&#x02010;Quinteros</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Diaz&#x02010;Villasenor</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Gutierrez&#x02010;Aguilar</surname>
</string-name>, et&#x000a0;al. <year>2006</year>
<article-title>Genetic heterogeneity of autosomal dominant hypercholesterolemia in Mexico</article-title>. <source>Arch. Med. Res.</source>
<volume>37</volume>:<fpage>102</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">16314194</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0030"><mixed-citation publication-type="journal" id="mgg3203-cit-0030">
<string-name>
<surname>Schmidt</surname>, <given-names>H. H.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Stuhrmann</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Shamburek</surname>
</string-name>, <string-name>
<given-names>C. K.</given-names>
<surname>Schewe</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ebhardt</surname>
</string-name>, <string-name>
<given-names>L. A.</given-names>
<surname>Zech</surname>
</string-name>, et&#x000a0;al. <year>1998</year>
<article-title>Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL&#x02010;apolipoprotein B particle and LDL&#x02010;receptor in a subject with clinical homozygous familial hypercholesterolemia</article-title>. <source>J. Clin. Endocrinol. Metab.</source>
<volume>83</volume>:<fpage>2167</fpage>&#x02013;<lpage>2174</lpage>.<pub-id pub-id-type="pmid">9626156</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0031"><mixed-citation publication-type="journal" id="mgg3203-cit-0031">
<string-name>
<surname>Singh</surname>, <given-names>S.</given-names>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Bittner</surname>
</string-name>. <year>2015</year>
<article-title>Familial hypercholesterolemia &#x02013; epidemiology, diagnosis, and screening</article-title>. <source>Curr. Atheroscler. Rep.</source>
<volume>17</volume>:<fpage>482</fpage>.<pub-id pub-id-type="pmid">25612857</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0032"><mixed-citation publication-type="journal" id="mgg3203-cit-0032">
<string-name>
<surname>Soria</surname>, <given-names>L. F.</given-names>
</string-name>, <string-name>
<given-names>E. H.</given-names>
<surname>Ludwig</surname>
</string-name>, <string-name>
<given-names>H. R.</given-names>
<surname>Clarke</surname>
</string-name>, <string-name>
<given-names>G. L.</given-names>
<surname>Vega</surname>
</string-name>, <string-name>
<given-names>S. M.</given-names>
<surname>Grundy</surname>
</string-name>, and <string-name>
<given-names>B. J.</given-names>
<surname>McCarthy</surname>
</string-name>. <year>1989</year>
<article-title>Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B&#x02010;100</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>
<volume>86</volume>:<fpage>587</fpage>&#x02013;<lpage>591</lpage>.<pub-id pub-id-type="pmid">2563166</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0033"><mixed-citation publication-type="journal" id="mgg3203-cit-0033">
<string-name>
<surname>Soufi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Rust</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Walter</surname>
</string-name>, and <string-name>
<given-names>J. R.</given-names>
<surname>Schaefer</surname>
</string-name>. <year>2013</year>
<article-title>A combined LDL receptor/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia</article-title>. <source>Gene</source>
<volume>521</volume>:<fpage>200</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">23510778</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0034"><mixed-citation publication-type="journal" id="mgg3203-cit-0034">
<string-name>
<surname>Soutar</surname>, <given-names>A. K.</given-names>
</string-name>
<year>2010</year>
<article-title>Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia</article-title>. <source>IUBMB Life</source>
<volume>62</volume>:<fpage>125</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">20073037</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0035"><mixed-citation publication-type="journal" id="mgg3203-cit-0035">
<string-name>
<surname>Soutar</surname>, <given-names>A. K.</given-names>
</string-name>, and <string-name>
<given-names>R. P.</given-names>
<surname>Naoumova</surname>
</string-name>. <year>2007</year>
<article-title>Mechanisms of disease: genetic causes of familial hypercholesterolemia</article-title>. <source>Nat. Clin. Pract. Cardiovasc. Med.</source>
<volume>4</volume>:<fpage>214</fpage>&#x02013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">17380167</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0036"><mixed-citation publication-type="journal" id="mgg3203-cit-0036">
<string-name>
<surname>Tada</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Kawashiri</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Ohtani</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Noguchi</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Nakanishi</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Konno</surname>
</string-name>, et&#x000a0;al. <year>2011</year>
<article-title>A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene</article-title>. <source>Atherosclerosis</source>
<volume>219</volume>:<fpage>663</fpage>&#x02013;<lpage>666</lpage>.<pub-id pub-id-type="pmid">21872251</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0037"><mixed-citation publication-type="journal" id="mgg3203-cit-0037">
<string-name>
<surname>Talmud</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Shah</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Whittall</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Futema</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Howard</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Cooper</surname>
</string-name>, et&#x000a0;al. <year>2013</year>
<article-title>Use of low&#x02010;density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case&#x02010;control study</article-title>. <source>Lancet</source>
<volume>381</volume>:<fpage>1293</fpage>&#x02013;<lpage>1301</lpage>.<pub-id pub-id-type="pmid">23433573</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0038"><mixed-citation publication-type="journal" id="mgg3203-cit-0038">
<string-name>
<surname>Tietge</surname>, <given-names>U. J.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Genschel</surname>
</string-name>, and <string-name>
<given-names>H. H.</given-names>
<surname>Schmidt</surname>
</string-name>. <year>2003</year>
<article-title>A Q136Stop mutation in the ARH gene causing autosomal recessive hypercholesterolaemia with severely delayed LDL catabolism</article-title>. <source>J. Intern. Med.</source>
<volume>253</volume>:<fpage>582</fpage>&#x02013;<lpage>583</lpage>.<pub-id pub-id-type="pmid">12702036</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0039"><mixed-citation publication-type="journal" id="mgg3203-cit-0039">
<string-name>
<surname>Urban</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Poss</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bohm</surname>
</string-name>, and <string-name>
<given-names>U.</given-names>
<surname>Laufs</surname>
</string-name>. <year>2013</year>
<article-title>Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis</article-title>. <source>J. Am. Coll. Cardiol.</source>
<volume>62</volume>:<fpage>1401</fpage>&#x02013;<lpage>1408</lpage>.<pub-id pub-id-type="pmid">23973703</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0040"><mixed-citation publication-type="journal" id="mgg3203-cit-0040">
<string-name>
<surname>Wilund</surname>, <given-names>K. R.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yi</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Campagna</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Arca</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Zuliani</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Fellin</surname>
</string-name>, et&#x000a0;al. <year>2002</year>
<article-title>Molecular mechanisms of autosomal recessive hypercholesterolemia</article-title>. <source>Hum. Mol. Genet.</source>
<volume>11</volume>:<fpage>3019</fpage>&#x02013;<lpage>3030</lpage>.<pub-id pub-id-type="pmid">12417523</pub-id></mixed-citation></ref><ref id="mgg3203-bib-0041"><mixed-citation publication-type="journal" id="mgg3203-cit-0041">
<string-name>
<surname>Yehya</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Souki</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Bitar</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Nemer</surname>
</string-name>. <year>2006</year>
<article-title>Differential duplication of an intronic region in the NFATC1 gene in patients with congenital heart disease</article-title>. <source>Genome</source>
<volume>49</volume>:<fpage>1092</fpage>&#x02013;<lpage>1098</lpage>.<pub-id pub-id-type="pmid">17110989</pub-id></mixed-citation></ref></ref-list></back></article>